Department of Veterinary Physiology and Pharmacology;
Texas A&M University;
College Station;
TX 77845;
United States;
Department of Biochemistry and Biophysics;
Texas A&M University;
College Station;
TX 77845;
United States;
Cancer Institute;
Cleveland Clinic;
Cleveland;
OH 44195;
United States;
Department of Medical Oncology;
Houston Methodist Hospital Cancer Center;
Houston;
TX 77030;
United States;
Specificity protein; Nuclear receptor 4A1; Pancreatic cancer; Transcription factors; Ligand inhibitors; Nuclear receptor 4A antagonists;